Immunome
IMNM
IMNM
29 hedge funds and large institutions have $41.1M invested in Immunome in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
36% less capital invested
Capital invested by funds: $64.6M → $41.1M (-$23.5M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Holders
29
Holding in Top 10
–
Calls
–
Puts
$5K
Top Buyers
| 1 | +$3.2M | |
| 2 | +$2.56M | |
| 3 | +$1.02M | |
| 4 |
RI
Ridgewood Investments
Springfield,
New Jersey
|
+$1M |
| 5 |
Millennium Management
New York
|
+$634K |
Top Sellers
| 1 | -$1.56M | |
| 2 | -$1.1M | |
| 3 | -$918K | |
| 4 |
BIM
Baldwin Investment Management
West Conshohocken,
Pennsylvania
|
-$860K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$169K |